May 28
|
Innocan Pharma Announces First Quarter 2025 Financial Results with Continued Strong Revenue Growth and Provides Corporate Update
|
Apr 30
|
Summit Hotel Properties (INN) Beats Q1 FFO Estimates
|
Apr 30
|
Summit Hotel Properties: Q1 Earnings Snapshot
|
Apr 30
|
SUMMIT HOTEL PROPERTIES REPORTS FIRST QUARTER 2025 RESULTS
|
Apr 29
|
INN or OHI: Which Is the Better Value Stock Right Now?
|
Apr 24
|
SUMMIT HOTEL PROPERTIES DECLARES FIRST QUARTER 2025 DIVIDENDS
|
Mar 14
|
INN or NHI: Which Is the Better Value Stock Right Now?
|
Feb 24
|
Summit Hotel Properties: Q4 Earnings Snapshot
|
Feb 24
|
SUMMIT HOTEL PROPERTIES REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS
|
Feb 20
|
Summit Hotel Properties Announces 2025 Annual Meeting of Stockholders
|
Feb 19
|
Park Hotels & Resorts (PK) Q4 FFO Miss Estimates
|
Feb 16
|
Summit Hotel Properties (INN): Among the Best Hotel Stocks to Buy According to Analysts
|
Feb 10
|
Innocan Pharma's Liposomal CBD Injection Shows Breakthrough Pain Relief in Elderly Donkey with Osteoarthritis
|
Dec 31
|
Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of C$635,444.60
|
Oct 3
|
Are Investors Undervaluing Summit Hotel Properties (INN) Right Now?
|
Sep 3
|
Innocan Pharma Advances Liposomal CBD with Positive Response from FDA Following Successful Pre-IND Meeting
|
Aug 29
|
Innocan Pharma Announces Closing of Private Placement and Grant of Stock Options
|
Aug 2
|
Here Is Why Bargain Hunters Would Love Fast-paced Mover Summit Hotel Properties (INN)
|
Jul 31
|
Q2 2024 Summit Hotel Properties Inc Earnings Call
|
Jul 30
|
Summit Hotel Properties swings back to profit in Q2 2024
|